Vertex Pharmaceuticals
VRTX
#174
Rank
$74.82 B
Marketcap
$292.55
Share price
3.19%
Change (1 day)
56.01%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2022 (TTM): $2.92 B

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $2.92 B. In 2021 the company made an earning of $2.79 B a decrease over its 2020 earnings that were of $3.17 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 2003 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$2.92 B4.77%
2021$2.79 B-12.06%
2020$3.17 B118.45%
2019$1.45 B129.12%
2018$0.63 B1415.4%
2017$0.04 B197.6%
2016$0.01 B-102.97%
2015-$0.48 B-28.53%
2014-$0.67 B-51.52%
2013-$1.37 B-32098.55%
2012$4.27 M
2010-$0.74 B24.05%
2009-$0.6 B
2007-$0.42 B83.1%
2006-$0.23 B59.02%
2005-$0.15 B3.28%
2004-$0.14 B-37.83%
2003-$0.23 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$21.33 B 629.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.39 B 460.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.84 B 133.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.60 B 467.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.56 B 192.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.14 B-104.51%๐Ÿ‡บ๐Ÿ‡ธ USA